![Frontiers | Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry Frontiers | Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry](https://www.frontiersin.org/files/MyHome%20Article%20Library/414593/414593_Thumb_400.jpg)
Frontiers | Hypervariable Region 1 in Envelope Protein 2 of Hepatitis C Virus: A Linchpin in Neutralizing Antibody Evasion and Viral Entry
![Frontiers | Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine Frontiers | Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine](https://www.frontiersin.org/files/Articles/701611/fmicb-12-701611-HTML/image_m/fmicb-12-701611-g001.jpg)
Frontiers | Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine
Secretion of Hepatitis C Virus Envelope Glycoproteins Depends on Assembly of Apolipoprotein B Positive Lipoproteins | PLOS ONE
![Frontiers | Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design Frontiers | Hepatitis C Virus (HCV)–Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design](https://www.frontiersin.org/files/Articles/371896/fimmu-09-01436-HTML/image_m/fimmu-09-01436-g001.jpg)